{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:44:36Z","timestamp":1793051076706,"version":"4.5.0"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC2105"],"award-info":[{"award-number":["2024NSFSC2105"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["2024qnGzn11"],"award-info":[{"award-number":["2024qnGzn11"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYYZZ25-17"],"award-info":[{"award-number":["CYYZZ25-17"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["YCX2024-01-65"],"award-info":[{"award-number":["YCX2024-01-65"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["YCX2025-01-42"],"award-info":[{"award-number":["YCX2025-01-42"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204308"],"award-info":[{"award-number":["82204308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Undergraduate Training Program for Innovation and Entrepreneurship","award":["2025137050013"],"award-info":[{"award-number":["2025137050013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polyethylene glycol (PEG) is used to graft liposomes with different densities to enhance their colloidal stability or blood circulation time, such as 0.3 mol % for commercial Onivyde and 5 mol % for DOXIL. However, the influence of PEG density on the mechanism of the accelerated blood clearance (ABC) of PEGylated liposomes remains unclear. In this study, we comparatively investigate the ABC phenomenon of liposomes modified with 0.3% and 5% molar ratios of PEG, and found that they displayed completely different mechanisms induced by anti-PEG antibodies. The ABC of liposomes grafted with 0.3 mol % PEG was induced by high-affinity anti-PEG antibodies, whereas the ABC of liposomes grafted with 5 mol % PEG was caused by both high and low-affinity anti-PEG antibodies. Free PEG can bind to high-affinity anti-PEG antibodies but not to low-affinity antibodies. Therefore, preinjecting a low dose of PEG completely inhibits the ABC of 0.3 mol % PEGylated liposomes while only partially decreasing the ABC of 5 mol % PEGylated liposomes in the PEG-immunized rats. These results suggest that the interfacial PEG density determines the mechanism of the ABC phenomenon of PEGylated liposomes, and the ABC of Onivyde can be readily inhibited by removing high-affinity anti-PEG antibodies in blood through preinjection of a low dose of PEG.<\/jats:p>","DOI":"10.1021\/acs.biomac.5c02353","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:46:12Z","timestamp":1774356372000},"page":"2598-2611","source":"Crossref","is-referenced-by-count":2,"title":["Poly(ethylene Glycol) Densities Determine the Mechanism\nof the Accelerated Blood Clearance of PEGylated Liposomes"],"prefix":"10.1021","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-848X","authenticated-orcid":true,"given":"Yaxin","family":"Zheng","sequence":"first","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Xu","sequence":"additional","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Abame","sequence":"additional","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Huang","sequence":"additional","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxue","family":"Su","sequence":"additional","affiliation":[{"name":"Chengdu Medical College , , ,","place":["Chengdu, China, 610500"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital) , , ,","place":["Chengdu, China, 610057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-1297","authenticated-orcid":true,"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Chongqing Medical University , , ,","place":["Chongqing, China, 400016"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026101207262898200_cit1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature,\nimmunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles\nin oncology: Facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Controlled\nRelease"},{"issue":"6","key":"2026101207262898200_cit3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1208\/s12249-024-02843-5","article-title":"Stealth\nNanocarriers in Cancer Therapy: a Comprehensive Review of Design,\nFunctionality, and Clinical Applications","volume":"25","author":"Saadh","year":"2024","journal-title":"AAPS\nPharmSciTech"},{"issue":"9","key":"2026101207262898200_cit4","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene Glycol Immunogenicity:\nTheoretical, Clinical, and Practical Aspects of Anti-Polyethylene\nGlycol Antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"2026101207262898200_cit5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood\nclearance (ABC) phenomenon: Clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit6","doi-asserted-by":"publisher","first-page":"102163","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies:\nCurrent situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano\nToday"},{"issue":"21","key":"2026101207262898200_cit7","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of Pre-Existing IgG and IgM Antibodies\nagainst Polyethylene Glycol in Healthy Individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"issue":"23","key":"2026101207262898200_cit8","doi-asserted-by":"publisher","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of Pre-existing IgG and\nIgM Antibodies against Polyethylene Glycol (PEG) in the General Population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"issue":"2","key":"2026101207262898200_cit9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1021\/acs.molpharmaceut.3c00774","article-title":"Impact of Anti-PEG\nIgM Induced via the Topical Application of a Cosmetic Product Containing\nPEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor\nDrug Formulations in Mice","volume":"21","author":"Gaballa","year":"2024","journal-title":"Mol. Pharmaceutics"},{"key":"2026101207262898200_cit10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","article-title":"Accelerated blood clearance of PEGylated\nnanoparticles induced by PEG-based pharmaceutical excipients","volume":"363","author":"Miao","year":"2023","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit11","doi-asserted-by":"publisher","first-page":"113821","DOI":"10.1016\/j.jconrel.2025.113821","article-title":"Impact of\npre-existing anti-polyethylene glycol (PEG) IgM on biodistribution\nand humoral response of intramuscularly administered PEGylated mRNA\nloaded lipid nanoparticle","volume":"383","author":"Abe","year":"2025","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jconrel.2022.12.039","article-title":"Anti-PEG antibodies before and after\na first dose of Comirnaty? (mRNA-LNP-based SARS-CoV-2 vaccine)","volume":"354","author":"Bavli","year":"2023","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit13","doi-asserted-by":"publisher","first-page":"123695","DOI":"10.1016\/j.ijpharm.2023.123695","article-title":"Effects of\nPEG antibodies on in vivo performance of LNP-mRNA\nvaccines","volume":"650","author":"Yang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"2026101207262898200_cit14","doi-asserted-by":"publisher","first-page":"879988","DOI":"10.3389\/fbioe.2022.879988","article-title":"PEG: Will It Come Back to You? Polyethelyne Glycol\nImmunogenicity, COVID Vaccines, and the Case for New PEG Derivatives\nand Alternatives","volume":"10","author":"Kong","year":"2022","journal-title":"Front. Bioeng. Biotech"},{"issue":"39","key":"2026101207262898200_cit15","doi-asserted-by":"publisher","first-page":"27077","DOI":"10.1021\/acsnano.4c11652","article-title":"Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine\nin Humans","volume":"18","author":"Kent","year":"2024","journal-title":"ACS Nano"},{"key":"2026101207262898200_cit16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2021.12.033","article-title":"Accelerated blood\nclearance and hypersensitivity by PEGylated liposomes containing TLR\nagonists","volume":"342","author":"Stavnsbjerg","year":"2022","journal-title":"J. Controlled Release"},{"issue":"3","key":"2026101207262898200_cit17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2\nmRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"2026101207262898200_cit18","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG Antibodies Boosted in Humans\nby SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"2026101207262898200_cit19","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s44222-025-00321-6","article-title":"Polyethylene glycol immunogenicity\nin nanomedicine","volume":"3","author":"Chen","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"2026101207262898200_cit20","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1038\/s41467-020-19947-8","article-title":"Enhanced dispersion stability of\ngold nanoparticles by the physisorption of cyclic poly(ethylene glycol)","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"2026101207262898200_cit21","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1158\/0008-5472.CAN-05-4007","article-title":"Development of a highly active nanoliposomal irinotecan\nusing a novel intraliposomal stabilization strategy","volume":"66","author":"Drummond","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"2026101207262898200_cit22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil (R)\n- The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit23","doi-asserted-by":"publisher","first-page":"113731","DOI":"10.1016\/j.jconrel.2025.113731","article-title":"Cancer\nnanomedicine from a clinician-scientist perspective: Lessons and prospects","volume":"382","author":"Gabizon","year":"2025","journal-title":"J. Controlled Release"},{"issue":"6","key":"2026101207262898200_cit24","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against Poly(ethylene glycol) Activate Innate\nImmune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"issue":"33","key":"2026101207262898200_cit25","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1021\/acsnano.4c05409","article-title":"Liposomes with Low Levels of Grafted Poly(ethylene\nglycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene\nglycol) Antibodies","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"issue":"7","key":"2026101207262898200_cit26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14737140.2016.1192471","article-title":"The safety\nand efficacy of Onivyde (irinotecan liposome injection) for the treatment\nof metastatic pancreatic cancer following gemcitabine-based therapy","volume":"16","author":"Passero","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"7","key":"2026101207262898200_cit27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1756283X17705328","article-title":"Update on the role of nanoliposomal\nirinotecan in the treatment of metastatic pancreatic cancer","volume":"10","author":"Rahman","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"7","key":"2026101207262898200_cit28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40265-017-0741-1","article-title":"Liposomal Irinotecan: A Review in Metastatic Pancreatic\nAdenocarcinoma","volume":"77","author":"Lamb","year":"2017","journal-title":"Drugs"},{"issue":"6","key":"2026101207262898200_cit29","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1073\/pnas.1324135111","article-title":"Remote loading\nof preencapsulated drugs into stealth liposomes","volume":"111","author":"Sur","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"2026101207262898200_cit30","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/acs.molpharmaceut.4c00278","article-title":"Optimized\nEnzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection\nin Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin","volume":"21","author":"Li","year":"2024","journal-title":"Mol. Pharmaceutics"},{"issue":"2","key":"2026101207262898200_cit31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0022-1759(02)00295-8","article-title":"A simple method for the determination of dissociation\nconstants by displacement ELISA","volume":"270","author":"Orosz","year":"2002","journal-title":"J. Immunol.\nMethods"},{"issue":"5","key":"2026101207262898200_cit32","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.molpharmaceut.3c01140","article-title":"The Effect of Lipid Composition on\nthe Liposomal Delivery of Camptothecin Developed by Active Click Loading","volume":"21","author":"Xie","year":"2024","journal-title":"Mol. Pharmaceutics"},{"key":"2026101207262898200_cit33","doi-asserted-by":"publisher","first-page":"114435","DOI":"10.1016\/j.ejpb.2024.114435","article-title":"Improved therapeutic index of the liposomal docetaxel-glutathione\nprepared by active click loading","volume":"203","author":"Jin","year":"2024","journal-title":"Eur. J. Pharm.\nBiopharm."},{"key":"2026101207262898200_cit34","doi-asserted-by":"publisher","first-page":"125248","DOI":"10.1016\/j.ijpharm.2025.125248","article-title":"Effects of\nlinkers on the development of liposomal docetaxel-glutathione prepared\nby active click loading","volume":"671","author":"Zhou","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"7","key":"2026101207262898200_cit35","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature Drug Release from Polyethylene\nGlycol (PEG)-Coated Liposomal Doxorubicin via Formation\nof the Membrane Attack Complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"2026101207262898200_cit36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the\nintegrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Senti","year":"2022","journal-title":"J. Controlled Release"},{"key":"2026101207262898200_cit37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2147\/IJN.S41701","article-title":"Accelerated drug release and clearance\nof PEGylated epirubicin liposomes following repeated injections: a\nnew challenge for sequential low-dose chemotherapy","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"2026101207262898200_cit38","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/acs.molpharmaceut.5c00024","article-title":"Effect of Prodrug Activation Rate\non In Vivo Drug Release and Antitumor Efficacy of SN38-Prodrug-Entrapped\nLiposomes","volume":"22","author":"Zhou","year":"2025","journal-title":"Mol. Pharmaceutics"},{"issue":"10","key":"2026101207262898200_cit39","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.drudis.2014.06.002","article-title":"Pharmacokinetics,\nmetabolism and distribution of PEGs and PEGylated proteins: quo vadis?","volume":"19","author":"Baumann","year":"2014","journal-title":"Drug Discovery Today"},{"key":"2026101207262898200_cit40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2019.08.017","article-title":"Overcoming\nanti-PEG antibody mediated accelerated blood clearance of PEGylated\nliposomes by pre-infusion with high molecular weight free PEG","volume":"311","author":"McSweeney","year":"2019","journal-title":"J. Controlled Release"},{"issue":"12","key":"2026101207262898200_cit41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jjco\/hyl109","article-title":"Phase 1 clinical study of pegylated liposomal doxorubicin\n(JNS002) in Japanese patients with solid tumors","volume":"36","author":"Fujisaka","year":"2006","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"2026101207262898200_cit42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00280-021-04294-2","article-title":"Phase I study of liposomal irinotecan (LY01610) in patients with\nadvanced esophageal squamous cell carcinoma","volume":"88","author":"Liu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"34","key":"2026101207262898200_cit43","doi-asserted-by":"publisher","first-page":"2500526","DOI":"10.1002\/smll.202500526","article-title":"Revealing the Incidence of the Accelerated\nBlood Clearance Phenomenon of PEGylated Liposomes in Individuals Using\na Drug-Release Reporter Liposome","volume":"21","author":"Zheng","year":"2025","journal-title":"Small"},{"issue":"2","key":"2026101207262898200_cit44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.xphs.2022.11.025","article-title":"Drug Stability\nand Minimized Acid-\/Drug-Catalyzed Phospholipid Degradation in Liposomal\nIrinotecan","volume":"112","author":"Kirpotin","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"2026101207262898200_cit45","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated\nliposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol.\nAdv. Mater."},{"key":"2026101207262898200_cit46","doi-asserted-by":"publisher","first-page":"113762","DOI":"10.1016\/j.jconrel.2025.113762","article-title":"Slow intravenous infusion\nreduces the accelerated blood clearance of PEGylated liposomes by\nremoving anti-PEG antibodies","volume":"382","author":"Zheng","year":"2025","journal-title":"J. Controlled\nRelease"},{"issue":"2","key":"2026101207262898200_cit47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40265-024-02133-1","article-title":"Liposomal Irinotecan: A Review as First-Line Therapy\nin Metastatic Pancreatic Adenocarcinoma","volume":"85","author":"Brown","year":"2025","journal-title":"Drugs"}],"container-title":["Biomacromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.biomac.5c02353","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/27\/4\/2598\/68820369\/acs.biomac.5c02353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/27\/4\/2598\/68820369\/acs.biomac.5c02353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:43:08Z","timestamp":1791805388000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article\/27\/4\/2598\/5137790\/Poly-ethylene-Glycol-Densities-Determine-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,4,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.biomac.5c02353","relation":{},"ISSN":["1525-7797","1526-4602"],"issn-type":[{"value":"1525-7797","type":"print"},{"value":"1526-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}